Baicalein inhibits macrophage lipid accumulation and inflammatory response by activating the PPARγ/LXRα pathway
© The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Immunology..
Lipid accumulation and inflammatory response are two major risk factors for atherosclerosis. Baicalein, a phenolic flavonoid widely used in East Asian countries, possesses a potential atheroprotective activity. However, the underlying mechanisms remain elusive. This study was performed to explore the impact of baicalein on lipid accumulation and inflammatory response in THP-1 macrophage-derived foam cells. Our results showed that baicalein up-regulated the expression of ATP binding cassette transporter A1 (ABCA1), ABCG1, liver X receptor α (LXRα), and peroxisome proliferator-activated receptor γ (PPARγ), promoted cholesterol efflux, and inhibited lipid accumulation. Administration of baicalein also reduced the expression and secretion of TNF-α, IL-1β, and IL-6. Knockdown of LXRα or PPARγ with siRNAs abrogated the effects of baicalein on ABCA1 and ABCG1 expression, cholesterol efflux, lipid accumulation as well as pro-inflammatory cytokine release. In summary, these findings suggest that baicalein exerts a beneficial effect on macrophage lipid accumulation and inflammatory response by activating the PPARγ/LXRα signaling pathway.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:209 |
---|---|
Enthalten in: |
Clinical and experimental immunology - 209(2022), 3 vom: 29. Sept., Seite 316-325 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Zhang, Zi-Zhen [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 03.10.2022 Date Revised 01.07.2023 published: Print Citation Status MEDLINE |
---|
doi: |
10.1093/cei/uxac062 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM342703633 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM342703633 | ||
003 | DE-627 | ||
005 | 20231226014731.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1093/cei/uxac062 |2 doi | |
028 | 5 | 2 | |a pubmed24n1142.xml |
035 | |a (DE-627)NLM342703633 | ||
035 | |a (NLM)35749304 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Zhang, Zi-Zhen |e verfasserin |4 aut | |
245 | 1 | 0 | |a Baicalein inhibits macrophage lipid accumulation and inflammatory response by activating the PPARγ/LXRα pathway |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 03.10.2022 | ||
500 | |a Date Revised 01.07.2023 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Immunology. | ||
520 | |a Lipid accumulation and inflammatory response are two major risk factors for atherosclerosis. Baicalein, a phenolic flavonoid widely used in East Asian countries, possesses a potential atheroprotective activity. However, the underlying mechanisms remain elusive. This study was performed to explore the impact of baicalein on lipid accumulation and inflammatory response in THP-1 macrophage-derived foam cells. Our results showed that baicalein up-regulated the expression of ATP binding cassette transporter A1 (ABCA1), ABCG1, liver X receptor α (LXRα), and peroxisome proliferator-activated receptor γ (PPARγ), promoted cholesterol efflux, and inhibited lipid accumulation. Administration of baicalein also reduced the expression and secretion of TNF-α, IL-1β, and IL-6. Knockdown of LXRα or PPARγ with siRNAs abrogated the effects of baicalein on ABCA1 and ABCG1 expression, cholesterol efflux, lipid accumulation as well as pro-inflammatory cytokine release. In summary, these findings suggest that baicalein exerts a beneficial effect on macrophage lipid accumulation and inflammatory response by activating the PPARγ/LXRα signaling pathway | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a LXRα | |
650 | 4 | |a PPARγ | |
650 | 4 | |a baicalein | |
650 | 4 | |a inflammatory response | |
650 | 4 | |a lipid accumulation | |
650 | 7 | |a Flavanones |2 NLM | |
650 | 7 | |a Flavonoids |2 NLM | |
650 | 7 | |a Interleukin-6 |2 NLM | |
650 | 7 | |a Liver X Receptors |2 NLM | |
650 | 7 | |a PPAR gamma |2 NLM | |
650 | 7 | |a Tumor Necrosis Factor-alpha |2 NLM | |
650 | 7 | |a baicalein |2 NLM | |
650 | 7 | |a 49QAH60606 |2 NLM | |
650 | 7 | |a Cholesterol |2 NLM | |
650 | 7 | |a 97C5T2UQ7J |2 NLM | |
700 | 1 | |a Yu, Xiao-Hua |e verfasserin |4 aut | |
700 | 1 | |a Tan, Wei-Hua |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Clinical and experimental immunology |d 1966 |g 209(2022), 3 vom: 29. Sept., Seite 316-325 |w (DE-627)NLM00001527X |x 1365-2249 |7 nnns |
773 | 1 | 8 | |g volume:209 |g year:2022 |g number:3 |g day:29 |g month:09 |g pages:316-325 |
856 | 4 | 0 | |u http://dx.doi.org/10.1093/cei/uxac062 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 209 |j 2022 |e 3 |b 29 |c 09 |h 316-325 |